These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7976492)

  • 21. Differential early posttransplant cytokine responses in living and cadaver donor renal allografts.
    Sadeghi M; Daniel V; Weimer R; Wiesel M; Hergesell O; Opelz G
    Transplantation; 2003 Apr; 75(8):1351-5. PubMed ID: 12717229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neopterin and a soluble interleukin-2 receptor in patients with systemic lupus erythematodes].
    Horák P; Hermanová Z; Ordeltová M; Faltýnek L; Kusá L; Budíková M; Vavrdová V; Opíchalová D; Ciferská H; Scudla V
    Vnitr Lek; 2004 Jun; 50(6):422-7. PubMed ID: 15346634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of tumor necrosis factor and soluble interleukin 2 receptor as markers of disease activity and prognosis in childhood leukemia and lymphoma.
    Kalmanti M; Karamolengou K; Dimitriou H; Tosca A; Vlachonikolis I; Peraki M; Georgoulias V; Kalmantis T
    Int J Hematol; 1993 Apr; 57(2):147-52. PubMed ID: 8494993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal cell carcinoma-associated immune impairment that may interfere with the response to cytokine therapy.
    Lauerová L; Dusek L; Simícková M; Rovný F; Spurný V; Rovný A; Slampa P; Zaloudík J; Rejthar A; Wotke J; Kovarík J
    Neoplasma; 1999; 46(3):141-9. PubMed ID: 10613588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mononuclear cell activation in Crohn's disease. Evaluation using serum assay of neopterin and interleukin-2 soluble receptors].
    Duclos B; Reimund JM; Lang JM; Coumaros G; Chamouard P; Lehr L; Baumann R; Koehl C; Weill JP
    Gastroenterol Clin Biol; 1990; 14(1):22-7. PubMed ID: 2311849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cancer chemotherapy on the relation between serum levels of soluble interleukin-2 receptors and CD4/CD8 ratio in patients with solid neoplasms.
    Lissoni P; Barni S; Tancini G; Viviani S; Rovelli F; Rescaldani R; Fiorelli G
    J Biol Regul Homeost Agents; 1989; 3(3):131-3. PubMed ID: 2560317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokines (IL-6, TNF-alpha, IL-1alpha) and soluble interleukin-2 receptor as serum tumor markers in multiple myeloma.
    Filella X; Blade J; Guillermo AL; Molina R; Rozman C; Ballesta AM
    Cancer Detect Prev; 1996; 20(1):52-6. PubMed ID: 8907203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melatonin as a new possible anti-inflammatory agent.
    Lissoni P; Rovelli F; Meregalli S; Fumagalli L; Musco F; Brivio F; Brivio O; Esposti G
    J Biol Regul Homeost Agents; 1997; 11(4):157-9. PubMed ID: 9582617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TNF-alpha, IL-6 and their soluble receptor serum levels and secretion by neutrophils in cancer patients.
    Jabłońska E; Kiluk M; Markiewicz W; Piotrowski L; Grabowska Z; Jabłoński J
    Arch Immunol Ther Exp (Warsz); 2001; 49(1):63-9. PubMed ID: 11266093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro modulatory effects of interleukin-3 on macrophage activation induced by interleukin-2.
    Lissoni P; Pittalis S; Brivio F; Tisi E; Rovelli F; Ardizzoia A; Barni S; Tancini G; Giudici G; Biondi A
    Cancer; 1993 Mar; 71(6):2076-81. PubMed ID: 8443757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Markedly elevated serum neopterin levels in patients with hemophagocytic histiocytosis].
    Shinmyozu K; Machigashira N; Itoyama T; Maruyama I; Osame M
    Rinsho Ketsueki; 1992 Apr; 33(4):545-7. PubMed ID: 1602622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Liberation of neopterin after lung resecting interventions with and without bronchial carcinoma].
    Gebhard F; Lenz J; Brückner UB
    Chirurg; 1996 Jul; 67(7):725-9. PubMed ID: 8776545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1.
    Lissoni P; Malugani F; Bonfanti A; Bucovec R; Secondino S; Brivio F; Ferrari-Bravo A; Ferrante R; Vigoré L; Rovelli F; Mandalà M; Viviani S; Fumagalli L; Gardani GS
    J Biol Regul Homeost Agents; 2001; 15(2):140-4. PubMed ID: 11501971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Blood levels of neopterin in patients with liver cirrhosis].
    Antoniello S; Di Martino G; Russo M; Bizzarro A; Auletta M; De Bellis A; Cacciatore L
    Ann Ital Med Int; 1989; 4(3):167-72. PubMed ID: 2484506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum concentration of the soluble interleukin-2 receptor for monitoring acute graft-versus-host disease.
    Miyamoto T; Akashi K; Hayashi S; Gondo H; Murakawa M; Tanimoto K; Harada M; Niho Y
    Bone Marrow Transplant; 1996 Feb; 17(2):185-90. PubMed ID: 8640164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum neopterin levels in liver cirrhosis.
    Antoniello S; Russo M; Bizzarro A; Auletta M; De Bellis A; Magri P; Russo P; Dell'Aquila A; Cacciatore L
    J Biol Regul Homeost Agents; 1989; 3(4):159-62. PubMed ID: 2638148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.
    Boyano MD; Garcia-Vázquez MD; López-Michelena T; Gardeazabal J; Bilbao J; Cañavate ML; Galdeano AG; Izu R; Díaz-Ramón L; Raton JA; Díaz-Pérez JL
    Br J Cancer; 2000 Oct; 83(7):847-52. PubMed ID: 10970683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the rejection markers tumor necrosis factor, ICAM-1, neopterin, interleukin-10, and soluble HLA in simultaneous pancreas and kidney transplantation with bladder drainage.
    Abendroth D; Storck M; Techt B; Zavazava N
    Transplant Proc; 1995 Dec; 27(6):3114-5. PubMed ID: 8539869
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum concentrations of interleukin-18 in early and advanced cancer patients: enhanced secretion in metastatic disease.
    Lissoni P; Brivio F; Rovelli F; Fumagalli G; Malugani F; Vaghi M; Secondino S; Bucovec R; Gardani GS
    J Biol Regul Homeost Agents; 2000; 14(4):275-7. PubMed ID: 11215816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.